News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Steven M. Teutsch, MD

Articles by Steven M. Teutsch, MD

Do Drug Formulary Policies Reflect Evidence of Value?

ByPeter J. Neumann, ScD,Pei-Jung Lin, MS,Dan Greenberg, PhD,Marc L. Berger, MD,Steven M. Teutsch, MD,Edward Mansley, PhD,Milton C. Weinstein, PhD,Allison B. Rosen, MD, ScD

January 1st 2006

Impact of 3-Tier Pharmacy Benefit Design and Increased Consumer Cost-sharing on Drug Utilization

ByPamela B. Landsman, MPH, DrPH,Winnie Yu, PharmD,XiaoFeng Liu, PhD,Steven M. Teutsch, MD,Marc L. Berger, MD

October 1st 2005

Latest Updated Articles

Do Drug Formulary Policies Reflect Evidence of Value?
Published: January 1st 2006 | Updated:
Impact of 3-Tier Pharmacy Benefit Design and Increased Consumer Cost-sharing on Drug Utilization
Published: October 1st 2005 | Updated:

Trending on AJMC

FDA to Restrict Ingredients Used in Mass-Marketed Compounded GLP-1s, Crack Down on Misleading Ads

Contributor: Reimagining Beneficiary Engagement in Accountable Care Models to Make America Healthy Again

Overcoming Mistrust in Clinical Trial Enrollment Through Community Resources: Susan Vadaparampil, PhD, MPH

Health Equity & Access Weekly Roundup: February 9, 2026

5 Things to Know About the Oral GLP-1 Era

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.

Alt Text

Alt Text